Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 3, 2010, Pages 499-503

  Steib, A ^a   Barre, J ^b   Mertes, M ^c   Morel, M H ^d   Nathan, N ^e   Ozier, Y ^f   Treger, M ^g   Samama, C M ^h  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^e DUPUYTREN UNIVERSITY HOSPITAL   (France)

^f Groupe Hospitalier Cochin ^*  (France)

^g UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^h HÔTEL DIEU   (France)

Author keywords

Heparin bridging; INR; Prothrombin complex concentrates; Surgery; Vitamin K; Vitamin K antagonists

Indexed keywords

ACENOCOUMAROL; ANTIVITAMIN K; FLUINDIONE; HEMOGLOBIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHYTOMENADIONE; PROTHROMBIN COMPLEX; WARFARIN;

AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDICATION; DRUG OVERDOSE; ELECTIVE SURGERY; HEART ATRIUM FIBRILLATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; FRANCE; HEMOGLOBINS; HEPARIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; SURGICAL PROCEDURES, ELECTIVE; SURGICAL PROCEDURES, OPERATIVE; THROMBOSIS; TIME FACTORS; VITAMIN K;

EID: 77949278722     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03685.x     Document Type: Article

References (26)

1. Hirsh J. Oral anticoagulant drugs. New Engl J Med 1999, 324:1865-75.
2. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists. Chest 1998, 133:160S-98S.
3. Douketis JD. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 2003, 108:3-13.
4. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997, 336:1506-11.
5. Dunn AS, Turpie A. Perioperative management of patients receiving oral anticoagulants. Arch Intern Med 2003, 163:901-8.
6. Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, Ansell J. The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2008, 133:299-339.
7. Clinical practice guidelines: prise en charge des surdosages en antivitamines K, des situations à risque hémorragique et des accidents 2hémorragiques chez les patients traités par antivitamines K en ville et en milieu hospitalier. Sang Thromb Vaiss 2008, 20. http://www.has-sante.fr, (N°spécial juillet 2008
8. Crowther MA, Douketis JD, Schnurr T, Steidl L, Mera V, Ultori C, Venco A, Ageno W. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial. Ann Intern Med 2002, 137:251-5.
9. Weibert RT, Le DT, Kayser SR, Rapaport SI. Correction of excessive anticoagulation with low-dose oral vitamin K. Ann Intern Med 1997, 126:959-62.
10. Hung A, Singh S, Tait RC. A prospective randomized study to determine the optimal dose of intravenous vitamin K in reversal of over-warfarinization. Br J Haematol 2000, 109:537-9.
11. Whitling AM, Bussey HI, Lyons RM. Comparing different routes and doses of phytonadione for reversing excessive anticoagulation. Arch Intern Med 1998, 158:2136-40.
12. Raj G, Kumar R, McKinney WP. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med 1999, 159:2721-4.
13. Crowther MA, Julian J, McCarty D, Douketis J, Kovacs M, Biagoni L, Schnurr T, McGinnis J, Gent M, Hirsh J, Ginsberg J. Treatment of warfarin-associated coagulopathy with oral vitamin K: randomised controlled trial. Lancet 2000, 356:1551-3.
14. Crowther MA, Donovan D, Harrison L, McGinnis J, Ginsberg J. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin. J Thromb Haemost 1998, 79:1116-18.
15. Brophy MT, Fiore LD, Deykin D. Low-dose vitamin K therapy in excessively anticoagulated patient, dose-finding study. J Thromb Thrombolysis 1997, 4:289-92.
16. Patel RJ, Witt DM, Saseen JJ, Tillman DJ, Wilkinson DS. Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation. Pharmacotherapy 2000, 20:1159-66.
17. Crowther MA, Schnurr T, Manfredi E, Kinnon K, Garcia D, Douketis JD. Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin. Haematologica 2005, 90:137-9.
18. Dezee KJ, Shimeall WT, Douglas KM, Shumway NM, O'Malley PG. Treatment of excessive anticoagulation with phytonadione (vitamin K). Arch Intern Med 2006, 166:391-7.
19. Dentali F, Ageno W, Crowther M. Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost 2006, 4:1853-63.
20. Woods K, Douketis JD, Kathirgamanathan K, Yi Q, Crowther MA. Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin. J Thromb Thrombolysis 2007, 24:93-7.
21. Wjasow C, McNamara R. Anaphylaxis after low dose intravenous vitamin K. J Emerg Med 2003, 24:169-72.
22. Denas G, Marzot F, Offeli P, Stendardo A, Cucchini U, Russo R, Nante G, Iliceto S, Pengo V. Effectiveness and safety of a management protocol to correct overanticoagulation with oral vitamin K: a retrospective study of 1043 cases. J Thromb Thrombolysis 2009, 27:340-7.
23. Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med 2009, 150:293-300.
24. Schuirmann DJ. A comparison of two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Pharmacodyn 1987, 15:657-80.
25. Sconce EA, Kamali F. Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen. Eur J Haematol 2006, 77:457-62.
26. Schurgers LJ, Shearer MJ, Hamulyak K, Stöcklin E, Vermeer C. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood 2004, 104:2682-9.